S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
DD
INSIDER · PHIO · Phio Pharmaceuticals Corp. · DIRECTOR

Deming David H

Every open-market transaction filed under this name, Nov 10 to Nov 13.

Filings
4
4 buys · 0 sells
Bought
$20K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−13.7%
avg move from buy price, 4 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 13PHIOPhio Pharmaceuticals Corp.DirectorBuy3,000$0.83$3K−13.9%
Nov 12PHIOPhio Pharmaceuticals Corp.DirectorBuy9,000$0.81$7K−11.8%
Nov 11PHIOPhio Pharmaceuticals Corp.DirectorBuy5,200$0.84$4K−14.4%
Nov 10PHIOPhio Pharmaceuticals Corp.DirectorBuy6,800$0.84$6K−14.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.